What is Aquaneering?
Aquaneering operates at the intersection of life sciences and advanced engineering, providing bespoke aquatic housing solutions primarily for zebrafish and other model organisms essential to modern biomedical research. With a legacy spanning over three decades, the company has refined its filtration technology to ensure high-fidelity, maintenance-free environments that are vital for reproducible scientific outcomes. Their market position is defined by a dual-focus on commercial laboratory efficiency and educational research support, offering modular, customizable systems that reduce the operational burden on research institutions. By prioritizing rapid deployment and system reliability, Aquaneering serves as a foundational partner for organizations pushing the boundaries of genetic and pharmaceutical discovery.
How much funding has Aquaneering raised?
Aquaneering has raised a total of $1.2M across 3 funding rounds:
Debt
$350K
Debt
$565K
Debt
$250K
Debt (2020): $350K with participation from PPP
Debt (2021): $565K led by PPP
Debt (2024): $250K supported by Live Oak Bank
Key Investors in Aquaneering
Live Oak Bank
A specialized financial institution known for providing lending solutions to small businesses and niche industry leaders across the United States.
PPP
Public-Private Partnership
What's next for Aquaneering?
With the recent influx of capital, Aquaneering is well-positioned to accelerate its product development lifecycle and expand its footprint in the global research equipment market. The strategic deployment of these funds will likely focus on enhancing the automation capabilities of their filtration systems, thereby addressing the growing demand for high-throughput, low-maintenance laboratory environments. As the company transitions into this next phase of growth, the focus remains on maintaining its reputation for technical excellence while scaling production to meet the needs of an increasingly complex biomedical research landscape. Future initiatives will likely involve deepening integration with digital monitoring tools to provide researchers with real-time data analytics, further cementing the company's role as an indispensable asset in the life sciences supply chain.
See full Aquaneering company page
